The drugs industry closed the day up 3%. OxiGene Inc ( OXGN), China Shenghuo Pharmaceutical Holdings Inc ( KUN), Novogen ( NVGN), and EntreMed Inc ( ENMD) were all decliners today within the drugs industry with Regeneron Pharmaceuticals Inc ( REGN) being today's featured drugs loser. Regeneron Pharmaceuticals Inc fell $1.44 (-2.3%) to $60.73 on average volume. Throughout the day, 1.2 million shares of Regeneron Pharmaceuticals Inc exchanged hands as compared to its average daily volume of 1.4 million shares. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. Regeneron Pharmaceuticals Inc has a market cap of $5.6 billion and is part of the health care sector. Shares are up 89.4% year to date as of the close of trading on Friday. TheStreet Ratings rates Regeneron as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity.
- You can view the full Regeneron Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.